ConductScience.org, home

Paper1557230

Selective inability of spleen antigen presenting cells from Leishmania donovani infected hamsters to mediate specific T cell proliferation to parasite antigens.

Rodrigues Júnior V and 2 others. Parasite Immunol, 1992. Cited by 37 papers, by iCite.

Cite this record

ConductScience Library. Selective inability of spleen antigen presenting cells from Leishmania donovani infected hamsters to mediate specific T cell proliferation to parasite antigens. Papers, record 1557230. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1557230

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Selective inability of spleen antigen presenting cells from Leishmania donovani infected hamsters to mediate specific T cell proliferation to parasite antigens.
PubMed
Journal
Parasite Immunol
PubMed
Year
1992
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
37
iCite
Relative citation ratio, by iCite
1.17
iCite
Revised in PubMed
2019-09-12
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rodrigues Júnior VV
2Da Silva JSJ S
3Campos-Neto AA

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigen-Presenting CellsMajor topic
Antigens, ProtozoanMajor topic
Leishmania donovaniMajor topic
Leishmaniasis, VisceralMajor topic
Lymphocyte ActivationMajor topic
SpleenMajor topic
T-LymphocytesMajor topic
Animals
Cricetinae
Disease Models, Animal
Immunity, Cellular
Lymph Nodes
Macrophages
Mesocricetus

Source PubMed

Download CSV of topics

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.

PMIDTitleJournalYearIn PapersSource
33680991Role of Cytokines in Experimental and Human Visceral Leishmaniasis.Front Cell Infect Microbiol2021https://conductscience.org/library/papers/33680991PubMed
25745863Recombinant NAD-dependent SIR-2 protein of Leishmania donovani: immunobiochemical characterization as a potential vaccine against visceral leishmaniasis.PLoS Negl Trop Dis2015https://conductscience.org/library/papers/25745863PubMed
25144181Combining cationic liposomal delivery with MPL-TDM for cysteine protease cocktail vaccination against Leishmania donovani: evidence for antigen synergy and protection.PLoS Negl Trop Dis2014https://conductscience.org/library/papers/25144181PubMed
24732039Combination of liposomal CpG oligodeoxynucleotide 2006 and miltefosine induces strong cell-mediated immunity during experimental visceral leishmaniasis.PLoS One2014https://conductscience.org/library/papers/24732039PubMed
24553602Animal models for the study of leishmaniasis immunology.Rev Inst Med Trop Sao Paulo2014https://conductscience.org/library/papers/24553602PubMed
24475071
Characterization of glycolytic enzymes--rAldolase and rEnolase of Leishmania donovani, identified as Th1 stimulatory proteins, for their immunogenicity and immunoprophylactic efficacies against experimental visceral leishmaniasis.
PLoS One2014https://conductscience.org/library/papers/24475071PubMed
23369975Experimental models in vaccine research: malaria and leishmaniasis.Braz J Med Biol Res2013https://conductscience.org/library/papers/23369975PubMed
22539989Evaluation of Leishmania donovani protein disulfide isomerase as a potential immunogenic protein/vaccine candidate against visceral Leishmaniasis.PLoS One2012https://conductscience.org/library/papers/22539989PubMed
22292030Leishmania donovani: immunostimulatory cellular responses of membrane and soluble protein fractions of splenic amastigotes in cured patient and hamsters.PLoS One2012https://conductscience.org/library/papers/22292030PubMed
19053149Photodynamic vaccination of hamsters with inducible suicidal mutants of Leishmania amazonensis elicits immunity against visceral leishmaniasis.Eur J Immunol2009https://conductscience.org/library/papers/19053149PubMed
10692051Modulation of CD11C+ splenic dendritic cell functions in murine visceral leishmaniasis: correlation with parasite replication in the spleen.Immunology2000https://conductscience.org/library/papers/10692051PubMed
9488418Transforming growth factor beta and immunosuppression in experimental visceral leishmaniasis.Infect Immun1998https://conductscience.org/library/papers/9488418PubMed
7595213Cloning and expression of a Leishmania donovani gene instructed by a peptide isolated from major histocompatibility complex class II molecules of infected macrophages.J Exp Med1995https://conductscience.org/library/papers/7595213PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1557230

GET https://conductscience.org/api/papers/v1/1557230/authors